Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CNR2 | P34972 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 1.00 |
| ▸ | FAAH | O00519 | 1/20 | 1.00 |
| ▸ | KCNK3 | O14649 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 0.91 |
| ▸ | MAPT | P10636 | 1/20 | 0.91 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.91 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anandamide SCHEMBL13100719 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1CNR2MEN1BLM | |
| Anandamide SCHEMBL7140616 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1CNR2MEN1BLM | |
| Anandamide SCHEMBL43143 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1CNR2MEN1BLM | |
| Anandamide SCHEMBL4109856 | 1.00 | CNR1 (1.00) | CNR1ALDH1A1CNR2MEN1BLM | |
| SCHEMBL15364953 | 0.98 | CNR1 (0.97) | CNR1ALDH1A1CNR2MEN1BLM | |
| SCHEMBL29512269 | 0.98 | CNR1 (0.97) | CNR1ALDH1A1CNR2MEN1BLM | |
| Anandamide SCHEMBL27412236 | 0.98 | CNR1 (0.97) | CNR1ALDH1A1CNR2MEN1BLM | |
| SCHEMBL4539275 | 0.98 | CNR1 (0.97) | CNR1ALDH1A1CNR2MEN1BLM | |
| SCHEMBL14700549 | 0.98 | CNR1 (0.97) | CNR1ALDH1A1CNR2MEN1BLM | |
| SCHEMBL14864037 | 0.98 | CNR1 (0.97) | CNR1ALDH1A1CNR2MEN1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10546 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146967-A1 | DEVICE AND SENSOR FOR DETECTION OF AN ANALYTE | REMINDED, INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| EP-4739302-A2 | HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS | Cella Therapeutics, LLC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4735431-A2 | MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4734961-A1 | NEW METHOD OF PRODUCING AN AQUEOUS MESOPARTICLE COMPOSITION COMPRISING A LIPOPHILIC COMPOUND | BIOGNTX R&D B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| EP-4731014-A2 | COMPOSITION AND METHODS FOR INCREASING LIPID SYNTHESIS IN MAMMARY EPITHELIAL CELLS | Can Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260102502-A1 | CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | claimed |
| US-12599600-B2 | Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-04-14 | — | — | US | claimed |
| EP-4713314-A1 | A BINDING SITE TO PREVENT ENDOCANNABINOID CELLULAR REUPTAKE | Universität Bern (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-3752608-B1 | GENE THERAPY OF THE FAAH PSEUDOGENE | UCL BUSINESS LTD (GB) | 2026-03-18 | — | — | EP | claimed |
| WO-1998020119-A1 | FATTY-ACID AMIDE HYDROLASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-05-14 | — | — | WO | claimed |
| US-5747524-A | BENZOTHIOPHENES AND BENZOFURANS | ELI LILLY AND COMPANY (US) | 1998-05-05 | — | — | US | claimed |
| EP-0766559-A4 | CANNABINOID RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0777415-A1 | ANANDAMIDE ANALOGUE COMPOSITIONS AND METHOD OF TREATING INTRAOCULAR HYPERTENTION USING SAME | Pate, David W. (NL) | 1997-06-11 | — | — | EP | claimed |
| US-5631297-A | MIXTURES WITH CYCLODEXTRIN | PATE DAVID W (NL) | 1997-05-20 | — | — | US | claimed |
| EP-0766559-A1 | CANNABINOID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-04-09 | — | — | EP | claimed |
| US-5576436-A | FLUORESCENT LABELED LIGANDS FOR MEASUREMENT OF RECEPTORS | PHARMACEUTICAL DISCOVERY CORPORATION (US) | 1996-11-19 | — | — | US | claimed |
| WO-1996002248-A1 | CANNABINOID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-02-01 | — | — | WO | claimed |
| WO-1996001558-A1 | ANANDAMIDE ANALOGUE COMPOSITIONS AND METHOD OF TREATING INTRAOCULAR HYPERTENTION USING SAME | PATE DAVID W (NL) | 1996-01-25 | — | — | WO | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |